Division of Cardiac Surgery, The Johns Hopkins University School of Medicine, Baltimore, Maryland.
Division of Cardiac Surgery, The Johns Hopkins University School of Medicine, Baltimore, Maryland.
Ann Thorac Surg. 2018 Oct;106(4):1088-1094. doi: 10.1016/j.athoracsur.2018.04.030. Epub 2018 Jun 20.
Bilateral internal mammary artery (BIMA) grafting in diabetic patients undergoing coronary artery bypass grafting remains controversial. Our study compared morbidity and mortality between (1) diabetic and nondiabetic BIMA patients and (2) diabetic BIMA versus diabetic patients who underwent left internal mammary artery (LIMA) grafting only.
Patients who underwent isolated coronary artery bypass grafting from July 2011 to June 2016 at any of the 10 Maryland Cardiac Surgery Quality Initiative centers were propensity scored across 16 variables. Diabetic BIMA patients were matched 1:1 by nearest neighbor matching to nondiabetic BIMA patients and were separately matched 1:1 to diabetic LIMA patients. We calculated observed-to-expected (O/E) ratios for composite morbidity/mortality, operative mortality, unplanned reoperation, stroke, renal failure, prolonged ventilation, and deep sternal wound infection and compared ratios among matched populations.
During the study period, 812 coronary artery bypass grafting patients received BIMA grafts, including 302 patients (37%) with diabetes. We matched 259 diabetic and nondiabetic BIMA patients. O/E ratios were higher in matched diabetic (versus nondiabetic) BIMA patients when comparing composite morbidity/mortality, reoperation, stroke, renal failure, and prolonged ventilation (all O/E ratios >1.0); however, the O/E ratio for operative mortality was higher in nondiabetic BIMA patients. We additionally matched 292 diabetic BIMA to diabetic LIMA patients. Diabetic BIMA patients had a higher O/E ratio for composite morbidity/mortality, operative mortality, stroke, renal failure, and prolonged ventilation.
In this statewide analysis, diabetic patients who received BIMA grafts (compared with diabetic patients with LIMA grafts or nondiabetic patients with BIMA grafts) had higher O/E ratios for composite morbidity/mortality as a result of higher O/E ratios for major complications.
在接受冠状动脉旁路移植术的糖尿病患者中,双侧内乳动脉(BIMA)移植仍然存在争议。我们的研究比较了(1)糖尿病和非糖尿病 BIMA 患者以及(2)糖尿病 BIMA 与仅接受左内乳动脉(LIMA)移植的糖尿病患者之间的发病率和死亡率。
2011 年 7 月至 2016 年 6 月期间,在马里兰州心脏手术质量倡议的 10 个中心中的任何一个中心接受单纯冠状动脉旁路移植术的患者根据 16 个变量进行倾向评分。糖尿病 BIMA 患者通过最近邻匹配与非糖尿病 BIMA 患者 1:1 匹配,并分别与糖尿病 LIMA 患者 1:1 匹配。我们计算了复合发病率/死亡率、手术死亡率、非计划性再次手术、中风、肾功能衰竭、延长通气、深部胸骨伤口感染的观察到的与预期的(O/E)比值,并比较了匹配人群中的比值。
在研究期间,812 例接受 BIMA 移植的冠状动脉旁路移植术患者,其中 302 例(37%)患有糖尿病。我们匹配了 259 例糖尿病和非糖尿病 BIMA 患者。与非糖尿病 BIMA 患者相比,匹配的糖尿病(与非糖尿病)BIMA 患者的复合发病率/死亡率、再次手术、中风、肾功能衰竭和延长通气的 O/E 比值更高(所有 O/E 比值>1.0);然而,非糖尿病 BIMA 患者的手术死亡率 O/E 比值更高。我们还将 292 例糖尿病 BIMA 与糖尿病 LIMA 患者相匹配。糖尿病 BIMA 患者的复合发病率/死亡率、手术死亡率、中风、肾功能衰竭和延长通气的 O/E 比值更高。
在这项全州范围内的分析中,与接受 LIMA 移植的糖尿病患者或接受 BIMA 移植的非糖尿病患者相比,接受 BIMA 移植的糖尿病患者的 O/E 比值更高,这是由于主要并发症的 O/E 比值更高。